Skip to main content

Table 2 Summary of biological domains

From: Towards a biological definition of ARDS: are treatable traits the solution?

Domain

Sample material

Example biomarkers

Advantage

Disadvantage

Endothelial injury

Plasma

Ang2

Easy to obtain

Pathophysiological contributor to lung injury development

Reflective of all endothelial dysfunction, not only in lung

Epithelial injury

Plasma

sRAGE. SP-D

Easy to obtain

Pathophysiological contributor to lung injury development

Not only related to epithelial injury but also to, i.e., clearance by the kidney

Epithelial injury

BALF

sRAGE

Not influenced by clearance

Evaluation at site of injury

Difficult to obtain sample

Local injury may not be reflective of the rest of the lung

Protein rich pulmonary edema

BALF

Total protein

Direct measurement of hallmark of ARDS

Difficult to obtain sample

Local injury may not be reflective of the rest of the lung

May not be targetable and reflective of injury to endothelium and epithelium

Protein rich pulmonary edema

EBC

Total protein

Non-invasive collection of EBC

Direct measurement of hallmark of ARDS

Requires specialized equipment that is not widely available

May not be targetable and reflective of injury to endothelium and epithelium

Protein rich pulmonary edema

HME fluid

Total protein

Non-invasive collection using standard HME

Direct measurement of hallmark of ARDS

Novel technique that needs to be validated further

May not be targetable and reflective of injury to endothelium and epithelium

Systemic host response

Plasma

IL-6, IL-8, TNFRI

Easy to collect

Used to classify subphenotypes

Not unique to ARDS and influenced by other organ dysfunction

Unclear contribution to lung injury

Not reflective of alveolar inflammation

Alveolar host response

BALF

Neutrophils, macrophages

IL-6, IL-8, TNFR1

Direct measurement of hallmark of ARDS

Pathophysiological contributor to lung injury development

Difficult to obtain sample

Local injury may not be reflective of the rest of the lung

  1. Ang angiopoietin, sRAGE soluble Receptor for Advanced Glycation End Product, SP-D Surfactant protein D, BALF broncho-alveolar lavage fluid, EBC exhaled breath condensate, HME heat moist exchanger, IL interleukin, TNFRI tumor necrosis factor receptor